• Thurs news: AbbVie Parkinson’s drug. Arch raises $3B biotech fund. Biogen dropping failed Sage tremor drug. AZ gets sought-after Tagrisso OK. Pfizer withdrawing sickle cell med. See more on our front page

Switzerland





I don’t get it. Help me understand.
Galderma is looking for a Head of International Market Access, building a team of HEOR, Access, Pricing experts... all new functions in Zug. Why? Cetaphil is retail, medical aesthetics self-pay. Our limited generic Rx portfolio cannot justify building a 2nd Shire.
 
































Similar threads

Replies
10
Views
2K